Cargando…
The effect of an hypoxic cell sensitizer on tumour growth delay and cell survival. Implications for cell survival in situ and in vitro.
A comparison has been made of the effects of the 2-nitroimidazole Ro-07-0582 on tumour growth delay after irradiation and tumour cell survival in vitro after irradiation in vivo. This compound has previously been shown to be a specific sensitizer of hypoxic cells. A dose of 1 mg/g body weight gave a...
Autor principal: | McNally, N. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1975
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024809/ https://www.ncbi.nlm.nih.gov/pubmed/1212418 |
Ejemplares similares
-
Hypoxic cell sensitizers: early or late in fractionated therapy?
por: Denekamp, J., et al.
Publicado: (1978) -
Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
por: Martin, W. M., et al.
Publicado: (1980) -
Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points.
por: Rofstad, E. K., et al.
Publicado: (1998) -
The radiation response of V79 and human tumour multicellular spheroids--cell survival and growth delay studies.
por: West, C. M., et al.
Publicado: (1984) -
Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)